Most
cancer and Stage 4 cancer patients will look at outcomes to help them
identify theiroptimal treatment facility. This article goes far beyond
the numbers, giving patients a deep understanding of how to evaluate
their options and statistically improve their cancer outcomes.
Envita’s decade plus of working with advanced and Stage 4 cancer’s most
complex cases is ideal to provide you with physician-direct perspective
on comparing conventional and alternative cancer centers – and
determining what is best for you.
Our approach concentrates on pointing out therapies and treatments that
regularly provide statistical and biological advantages for patients
suffering with various cancer types.
Cancer Treatment Statistics Can be Deceiving
There are many reasons why “statistically significant” doesn’t
necessarily mean improvement in your condition or life. One must first
determine whether the correct factors are being examined in the provided
survival data. For example, is “the response rate” offered for a
specific cancer type’s treatment regimenshort-lived or sustained with
significant improvement inlife quality?
The real problem is that many of these cancer treatment "responses" can
often be temporary, or even fleeting. Even among patients with cancers
of identical stage and type can there are often different response rates
based on the behavior and genetic variations of each person’s tumors.
This is an important thought to consider as it touches on the model
specifically used by cancer hospitals and drug companies – as you can
tell, however, it comes with significant flaws.
The notion of response rates being deceiving, closely mirrors a more
fundamental problem with cancer statistics as a whole. Envita Medical
Centers makes survival and overall quality of life for patients, our
most important measures of success.
Here is an Example of Static Problems Cancer Treatment - Proving the Point
Hereis an example to demonstrate some of the problems with a “statics based”response to cancer treatment:
Treatment Protocol 1 (TP1) has 35 percent rate of response while
Treatment Protocol 2 (TP2) has a 75 percent rate. However, if we find
TP2 is short-lived, it certainly does not mean that it is a better
treatment. Moreover, if TP2 is far more toxic than TP1, it is likely
that the quality of life for TP2 patients will be considerably lower.
Thesegames of data manipulation and “telling only part of the story,”
are often played by pharmaceutical companies and cancer centers to bring
patients in.
Other cancer centershave adopted the approach of implementing will
“special criteria” to skew their results.For example, their data
information may state“patients that completedour protocol.” This is an
indication that unscrupulous tactics were implemented to create
exclusionary criteria, thereby diminishing undesirable outcomes and
“appearing better” at first glance.
Statics are regularly manipulated in numerous ways -it is not uncommon
to see organizations show enhanced results by including tricky (or
concealing relevant) survival data.
Without specific calculation criteria, results are unreliable at best –
making such criteria absolutely critical for objective comparison. Keep
in mind, if it looks too good to be true, it likely is.
Statics That Matter: The Bottom Line Is - Patients Can Improve Their Statics and Save Their LivesWith Cancer Treatment
In our experience, what patients are seriously askingfor is the best
treatments available to help them find remission, achieve a cure, and
live. That pretty much is the bottom line.
So, exercise caution with the statistical data and white papers that you
read. We have found that, no matter how large or smallthe organization,
the data provided by medical groups can be somewhat deceiving andlikely
far more convoluted then they appear – particularly those sources made
available online.
It is important to systematically consider both conventional and
alternative medicine and discuss the true “game changers” that may
statically and significantly help you to achieve yourgoal.
Remember, cancer is individualized and cannotbe neatly ushered into
broad categories of type and stage. This can be seen in latest
treatments for cancer being administered around the world. Genetic and
personalized immunotherapies are beginning to replace the one size fits
all models – because their results are superior.
Why is this true? Because every patient is different – including their
respective cancer’s causative agents, their tumor'sspecific
metabolism,and even the way the patient handles side effects. There is
no question that the future of cancer treatment is personalization, and
Envita is leading the way.
Stage 4 Cancer Treatments Impact Statistics – Conventional and Alternative
Looking at the Standard of Care for Cancer Treatment
Report Shows Conventional Cancer Treatment Centers - Worst SEER Statistical Scores
There is a lot of fear surrounding cancer treatment. Much of this stigma
comes from poor results, standardized treatment plans, abysmal side
effects, no customization, disease recurrence, and of course, the loss
of life.
A major fault of traditional cancer treatment is its singular focus on
tumor "response" or shrinkage. In fact, research has shown "response"
does not necessarily correlate to increased survival time in adults.
When we hear that a traditional cancer treatment has had a 20% or 30%
success rate with late-stage cancer, in actuality that means patients
have only experienced a 20-30% "response" rate, or tumor shrinkage. This
statistically has little or nothing to do with the patients' quality of
life or survival time. In our opinion, this misconception is largely
responsible for the poor results found in the NCI Surveillance,
Epidemiology, and End Results Program (SEER) database report. The SEER
web site can be accessed at seer.cancer.gov.
A Deeper Look at SEER Trends in Conventional Cancer Centers
Some cancer centers areposting how “their results are better” than the
conventional system or SEER numbers. That is not hard to do,
particularly as it applies to late stage or Stage 4 cancers.
Doctors Faguet and Morgan* have clearly demonstrated that chemotherapy
is only 2% effective in the treatment of late-stage and Stage 4 cancer,
for a 5-year survival periodor better. For this reason, most centers do
not dare report beyond 2-3 years let alone 5 beyond initial diagnosis –
quite simply the results are not going to be in their favor.
Just to provide some perspective, Envita’s typical patient is entering
our medical center 2-3 years after initial diagnosis and is often
refractory to conventional and many times refractory to several
alternative therapies. For this reason, Envita is extremely qualified to
point out those treatments that are truly “statistic beaters” for
patients. It is our contention that the sooner patients incorporate them
into their treatment plans, the more likely the chance for exponential
improvements to manifest beyond statistical expectations.Hereunto
forward, all data discussed will be for Stage 4 cancers.
Please note that the percentages provided in the following chapters are
estimates (approximates) and not exact, as each patient is different and
may not respond to a particular conventional or alternative treatment.
Additionally, it should be understood that various details also impact
the improvements to survival outcomes and patient quality of life. The
purpose of this article is not to cover every treatment offered, rather
provide some important examples to provideclear perspective as well as
some definitive bearings by which to assist throughout the information
gathering process.
Part I conventional Chemotherapy
Outperforming SEER NumbersthroughEnhanced Conventional Treatments with Chemotherapy - 75%Improvement for Most Cancers
At Envita, wepride ourselves on providing state-of-the-artconventional
and advanced alternative medicine for cancer – what we call
“integrative” medicine. Two of the most common conventional therapies
are chemo and radio (radiation.)
By the time most patientsarrive at Envita, they are either frightened by
or turned off by these traditional treatment protocols, by and large,
because of their own poor experiences.And while Envita has options to
help patients steer clear of these treatments – chemotherapy and
radiation can play both important and effective roleswhen used minimally
- not as the lone treatment.
Second Method to Outperform SEER Numberswith Chemotherapy Cancer Treatment
Chemotherapy iswidely used by the biggest and most well-recognized
hospitals as a staple for cancer treatments. However, the protocols they
follow are derived from large group averages. The resultant problem
with this model is that our genetic and molecular testing on Stage 4
cancer shows that75% of patientswere clearly administeredthe
wrongchemotherapy –one wholly ineffective for their specific cancer
genetics and metabolism.
As a result, these patients suffer needlessly with heavy side effects,
compromised quality of life, and substandard results, all while their
statistics spiral downward.
Moreover, these patients were likely being reassured, all the while,
that their chemotherapy was working (at least in the short-term) or
having a “response.”Really all the treatment had rendered was making the
cancer and tumor more resistant.
By correctly utilizing Envita’s comprehensive strategy and implementing
genetic and molecular profiling,we immediately seemajor improvements in
drugchoicesanda quantum leap toward superior, long-term effectiveness.
To what degree?Roughly a 40% boost to statics across the board.
We envision a future where this will be the only method by which
chemotherapy will be administered. In the meantime, while pharmaceutical
companies and politics have a stronghold, we will continue to see the
business machine satisfied to sell huge quantities of ineffective drugs
for Stage 4 cancers - maintaining the game of large protocols as the
standard.
40% Average Specificity Increase with Genetic and Molecular Profiling
The second major problem with chemotherapy comes part and parcel with
the all-too-typical practice of immediately administeringlarge doses –
rather than the more practical and effective technique calling for low
micro doses using insulin potentiation. By directly targeting the
specific cancer cells in such a manner, it is possible to achievemaximum
benefit while minimizing side effects. Envita’s proprietary
technique,GTF (genetically targeted Fractioned Chemotherapy),pairs
molecular genetic testing and thecancer cells sugar metabolism to target
them directly.
The end result is far fewer side effects coupled with a considerably
higher quality of life and a greatly enhanced opportunity for long-term
survival.
GTFCan Provide 75% Improvement in Life Quality and Survival Time for Stage 4 Cancer Patients
GTF can provide a 75% overall average improvement over the SEER report
for Stage 4 cancers, starting 3 years after initial diagnosis. At
Envita, we customarily receive patients from 2-3 years, post-diagnosis,
as most are channeled through standard methods until they have
personally recognized them to be unsatisfactory.
Part II Conventional Radiation treatment
Outperforming SEER Numbers by 75-80% with Newest in Conventional Radiation Treatment
Generally speaking, radiation treatment tends to be the most
misunderstood therapy treatment. Lack of understanding contributes to
poor cancer patient statistics at all stages.
There are two main areas to understand with radiation:
1. Radiation therapy is often improperly prescribed because the surgeon
or other care provider uses their own treatment method – oftentimes one
that is cancer approved, but not necessarily ideal for the patient.
Consider, for a moment, a scenario wherea prostate cancer patient would
be prescribed robotic surgery or radiation seed therapywhen, in fact,
(if size and location are appropriate) they would respond far better to
cyber knife radiation. This non-invasive technique could provide
life-changing results and be done with no down time or side effects.
If they were not made aware of all their options they would likely have
been faced with the standard several weeks of down time/ recovery that
comes with the robotic surgery, including the plausibility of
uncomfortable complications. Moreover, this was only an example of an
obvious, early stage cancer with many possibilities for remission.
Imagine the outcome if all the best options were not weighed in a case
of Stage 4 cancer planning – it could be far worse than the extra two
weeks in bed and discomfort. In fact, it could prove lethal.
It should also be pointed out about the above example, that cyber knife
decreases the chance of metastasis due to the absence of surgical
removal. As radiation technology improves dramatically, the key is to
target the tumor(s) without administering too much whole-bodyradiation
while keeping the immune system intact. When used correctly, extension
of life and its quality therewith, can dramatically change a Stage 4
statistic – particularly when combined with targeted immunotherapy. At
Envita, we have seen such methodology bring about remissions, even in
late-stagedisease.
2. Radiation can be an expensive propositionfor a hospital or cancer
groups. If they own the equipment and a billing code, they will use it.
This therapy type is among the most profitable for cancer hospitals and
it was estimated that Cancer Centers of America bills - as much as 600
million every 6 months in tomotherapy alone.
However, just because a hospital owns a particular machine or device,
does not necessarily mean it is ideal for a given patient’s condition.
Rather, what we see instead are patients being administered treatments
without being provided superior options that may very well be available.
It is indisputable that the wrong radiation can cause extreme side
effects and a significant decline in immune function. In Stage 4 cancer,
that can be devastating.
At Envita, we have top radiation oncologyconsultants, and access to all
the latest technology in targeted,next-generation,radiation therapy
including tomothearpy, cyber knife,and proton beam without being
fiscally overstressed. That provides Envita the luxury of putting
patients first, and having the ability to incorporate properly timed
immunotherapyto improve results.
Should radiation beconsideredat Envita,it is done with definitive plans
to knock out tumors quickly with the lowest possible total body doses,
thereby leaving the immune system intact. In the past, we have helped
many patients avoid surgery in early diseasestages while decreasing the
risk of metastasis and serious side effects. The precision of
modern-dayequipment is accurate within1mm and with virtually no
collateral damage.
At Envita, we implement a trulyintegrative and advanced approach to
cancer treatment. Correct combinations are critical to helping patients
improve their overall outcomes.
A Look at Improving Statistical Outcomeswith Alternative Cancer Centers
Simply put, Envita Medical Centers is among (if not the most) advanced
alterative cancer treatment centers in the world.Our proprietary
alternative medicine methods and treatments make all the difference in
the world, improving statistics across the board. We can help you
evaluate what is best for your specific condition.
So what is truly the best way to compare alternative cancer centers
beyond relying upon easily skewed statistics? To begin, it is wise to
determining if their focus is committed to improving quality of life and
survival for their patients.
How Vitamin C and Ozone Therapy as Cancer Treatments Can Enhance Statics: Up to 70% Life Quality, 50% Survival Time
Oxidative therapies should be staples in the treatment ofmanycancers.
However, only alternative medical centers across the globe take
advantage of them. Vitamin C works on many levels as a natural form of
chemotherapy and, when aided with ultraviolet light, can really improve
the action on other conventional treatments by increasing reactive
oxygen species.
To learn more about these therapies, please visit our peer reviewed vitamin C and Ozone articles.
Overview - Why Vitamin C Oxidative Therapies Don’t Always Work in Cancer Treatment
At Envita, we offer our own speed drip technology and sustained release
intravenous Vitamin C delivery demonstrated to significantly outperform
all others. One Envita treatment is roughly 4 times more therapeutic.
However, there are several reasons thatoxidative therapymight not
working on all patients – at least initially. Some tumors produce larger
amounts of enzyme catalase, preventing the beneficial oxidizing effect
of hydrogen peroxide produced by high-dose Vitamin C. This can widely be
remedied by initially administering ozone therapy, thereby increasing
Vitamin C efficacy.
The other problem that stand in the way of oxidative therapy
resultsstems from not having enough oxygen outside the cell for the
Vitamin C to produce toxic hydrogen peroxide on the tumor. Again, by
using ozone properly, prior to the Vitamin C dosing, this obstacle may
be corrected.
With this approach, it is possible for some patients to realize and maintain remission.
Recognizing Who’s Who in the World of Cancer Treatments by What Else - Their Treatments
You need not look further than the treatments a center offers (and the
scope and range of their doctors) to determine why they may (or may not)
get desirable results. Once you have, you better able to evaluate your
options.
Chemotherapy Sensitivity Screening and Target Radiation
Treatments provided by hospitals and cancer centers that do heavy
advertising are usually limited to their own equipment. They may own old
or new –but will use them liberally, as long as they have their own
billing codes.
At Envita, we provide patients with a full spectrum of options – the
very best available. Wepersonalize and tailor your treatment to help you
and even work to limit chemotherapy and radiation – administering only
when needed, as there are many other tools available to enhance results.
In simple terms, we are the alternative medicine experts.
Other Alternative Therapies Being Researched as Cancer Treatments
Most alternative centers offer ahigh-doseVitamin C treatment to their
patients. Some may also administer ozone therapy, depending on their
state and licensure. Those are always good to see from the start.
However,during your search, you may run across things like mistletoe
treatment, Resveratrol treatment, Sodium Bicarbonate treatments, and
myriad supplements and teas. And while many of these therapies mentioned
may have their place with correct application and setting, ultimately
not one of them has been a hit cure or wonder.
Envita has been exposed to so many therapies, we are utterly confident
that our personalized approach of combining idyllictreatment
combinations with passionate doctors, is the key to achieving
significant results - really moving the statics in your favor.
Deeper Look atAlternative Medicine Cancer Treatment Centers with Immunotherapy
A shrewd way to evaluate Alternative Cancer Treatment Centers is by
determining the level of immunotherapy available at each given center.
Here is a solid explanation of immunotherapy’s different levels that may
be applied to such comparative analysis.
Entry Level immunotherapy- This is seen at most naturopathic medical
practices, Chiropractor offices, acupuncturist operations, and health
food stores and is most easily recognized by the administering of immune
system building oral supplements, nutrition, and teas. The level of
background in cancer immunotherapy can vary greatly among these
providers. Nevertheless, you will find that entry level is what is most
often used in combination with chemotherapy and radiation. While it does
have some positive effects, it is typically offered to demonstrate a
particular practice or institution is “open minded” while remaining
focused on pharmaceutical-based solutions.
Middle Level immunotherapy- Administers forms of immunotherapy like
intravenous high-dose Vitamin C for cancer patients. Iscador, mistle
toe, Resveratrol, Sodium Bicarbonate and other homeopathic botanicals
may also be included in their treatment protocols. By and large middle
level is provided by Naturopathic doctors in some states, as well as by
some more open-minded MDs and DOs. Oftentimes these middle level
practices will offer some entry level methods as well.
Higher Level immunotherapy- Aims to potentiate various forms of
chemotherapy via immunotherapy. Their providers (Dos or MDs) carry the
licensure necessary to practice these methods and will likely integrate
all methodologies mentioned above. Their goal is to target cancer cells
while working to get the immune system functioning at a high level.
Highest Level immunotherapy- This method refers directly to the science
of building vaccines derived from the patient’s own immune system to
fight cancer. Cellular-based immunotherapy extracts while blood cells
and expands them to more effectively battle the disease. This is akin to
an “immune system transplant” of sorts and originated some 25 years ago
with cytotoxic T cells. The science and methodology of this highest
level continue to advance rapidly and are greatly available in countries
outside the United States. That being said, a newly approved drug has
just been accepted in the United States for Stage 4 prostate cancer
patients.
Next Gen Immunotherapy- This is a Cellular-based immunotherapy founded upon genetic manipulation.
All methods of immunotherapy are currently offered at Envita
international medical centers. And with those therapies we have the
experience and training to determine ideal combinations in case-by-case
scenarios.
What Most Oncologists Consider Immunotherapy and the Important Alternatives They Ignore
Cell-based immunotherapy is typically recognized domestically when a
drug trial is being sponsored. By and large however, the science is
typically ignored. While cytokines are referenced, conventional
treatment centers continually leave them out of cancer protocols. It
seems that conventional oncologists worry that their patient will be
taken off normal chemotherapy treatments for an unproven alternative.
This unfounded fear stands in the way of most patients fully engaging in
the best treatment plan possible to fight their disease.
Stacking the Statics in Your Favor
Natural Killer Cells Treatment and Technology
Envita’s proprietary natural killer cell cancer vaccine (AAIT) is a
highly efficacious treatment, providing a uniquely targeted way to fight
cancer – in particular, metastatic disease. You can learn more about
AAIT on Envita’s AAIT Cancer Vaccine page.
Please note, Envita’s international centers provide numerous treatments not yet available in the U.S.
The Real Goal in Any Cancer Treatment is Long Term Remission
Most of us continue to grow more savvy and aware as we are faced with an
endless barrage of marketing and advertising campaigns to lure us to
myriad products and services. For some reason, when we think of the
medical industry, we tend to assume that they are above such practices
of miscommunication and manipulation.
However, when there are billions of dollars at stake, corners are cut
and data is often manipulated. Sure, we agree that doctors strive to
serve their patients, but that doesn’t mean that the institution that
writes their check isn’t at all motivated by the almighty dollar –
something that can corrupt and contaminate the environment of care.
In other words, do not be fooled. Your life is far too valuable.
In conventional cancer treatment models, “wait and see” has become a far
too common approach. After treatment is administered, patients wait to
see how or even if their bodies respond to treatment - and how long the
effects will last.
Oncologists use the term “remission” and not “cure,” because it is
unknown whether the cancer will come back later.There still may be
cancer cells left in the body, even though there is no sign of it at the
time. These cancer cells, which can break out of dormancy, often
account for the recurrence of disease.
At Envita, we wish to build the best personalized treatment plan for you
or your loved ones’ cancer by using the most targeted and comprehensive
approaches from around the world.
No matter what route you chose, we want to personally welcome you to
Envita Medical Centers and let you know we are here for you – the
uncontested leaders in personalized cancer treatment.At Envita aim to
continually set the bar for improving cancer statistics – one patient at
a time.
Article Source: http://www.compensationsecrets.co.uk/
Rate This Article |
Add Comments |
Send To Friends
